{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T12:07:26Z","timestamp":1763726846060,"version":"3.45.0"},"reference-count":89,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Cardiovascular Therapy"],"published-print":{"date-parts":[[2015,1,2]]},"DOI":"10.1586\/14779072.2015.986464","type":"journal-article","created":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T11:15:43Z","timestamp":1417432543000},"page":"23-31","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":6,"title":["Azelnidipine and glucose tolerance: possible indications and treatment selection for hypertensive patients with metabolic disorders"],"prefix":"10.1586","volume":"13","author":[{"given":"Kazunori","family":"Shimada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsumi","family":"Miyauchi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Daida","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2014,12]]},"reference":[{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1586\/erc.13.18"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60987-8"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-13-0702"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc05-2366"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.37.4.1053"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.2147\/VHRM.S4331"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.51.57"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-5198(19)40076-0"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.53.264"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40268-013-0006-8"},{"key":"e_1_3_3_15_1","first-page":"122","article-title":"Azelnidipine. CS 905, Calblock, RS 9054","volume":"4","year":"2003","unstructured":"Azelnidipine. CS 905, Calblock, RS 9054. Drugs R D 2003;4:122-5","journal-title":"Drugs R D"},{"key":"e_1_3_3_16_1","first-page":"698","article-title":"Clinical study with azelnidipine in patients with essential hypertension. Antiarteriosclerotic and cardiac hypertrophy-inhibitory effects and influence on autonomic nervous activity","volume":"57","author":"Nada T","year":"2007","unstructured":"Nada T, Nomura M, Koshiba K, et al. Clinical study with azelnidipine in patients with essential hypertension. Antiarteriosclerotic and cardiac hypertrophy-inhibitory effects and influence on autonomic nervous activity. Arzneimittelforschung 2007;57:698-704","journal-title":"Arzneimittelforschung"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.106.108894"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.31.525"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-9-82"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-10-79"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1177\/1479164112447310"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-200405000-00016"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2009.03911.x"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-11-0141"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2011.03.013"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1975.00330060055007"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.110.162446"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000205119.19804.08"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehm400"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2261-12-89"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.548461"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000179604.42845.8d"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.104.528166"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02527-7"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.20.2191"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000236119.96301.f2"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000125726.92964.ab"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.5551\/jat.E515"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00400728"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.2355"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60108-1"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.15.1882"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000236119.96301.f2"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2011.01.064"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1001121"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f6745"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-004576"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajh.2008.17"},{"issue":"2","key":"e_1_3_3_49_1","doi-asserted-by":"crossref","first-page":"S313","DOI":"10.2337\/dc11-s246","article-title":"Diuretic treatment of hypertension","author":"Grossman E","year":"2011","unstructured":"Grossman E, Verdecchia P, Shamiss A, et al. Diuretic treatment of hypertension. Diabet Care 2011(Suppl 2):S313-19","journal-title":"Diabet Care"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0000000000000012"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/tpj.2012.34"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007990903533681"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S49767"},{"key":"e_1_3_3_54_1","first-page":"711","article-title":"Pharmacological characteristics of azelnidipine, a long-acting calcium antagonist, having vascular affinity (No. 2)\u2013antihypertensive effect and pharmacokinetics in spontaneously hypertensive rats (SHR) [in Japanese]","volume":"30","author":"Sada T","year":"2002","unstructured":"Sada T, Mizuno M, Miyama T, et al. Pharmacological characteristics of azelnidipine, a long-acting calcium antagonist, having vascular affinity (No. 2)\u2013antihypertensive effect and pharmacokinetics in spontaneously hypertensive rats (SHR) [in Japanese]. Jpn Pharmacol Ther 2002;30:711-20","journal-title":"Jpn Pharmacol Ther"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-5198(19)40137-6"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0b013e3182776c28."},{"key":"e_1_3_3_57_1","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0026-895X(25)12561-3","article-title":"Kinetics of binding of membrane-active drugs to receptor sites. Diffusion-limited rates for a membrane bilayer approach of 1,4-dihydropyridine calcium channel antagonists to their active site","volume":"27","author":"Rhodes DG","year":"1985","unstructured":"Rhodes DG, Sarmiento JG, Herbette LG. Kinetics of binding of membrane-active drugs to receptor sites. Diffusion-limited rates for a membrane bilayer approach of 1,4-dihydropyridine calcium channel antagonists to their active site. Mol Pharmacol 1985;27:612-23","journal-title":"Mol Pharmacol"},{"key":"e_1_3_3_58_1","first-page":"191","article-title":"905, a new calcium antagonist-III : a multiple dose study on healthy volunteers. [in Japanese]","volume":"16","author":"Nakashima M","year":"2000","unstructured":"Nakashima M, Kawabata K, Sasahara K, Phase I study of CS-905, a new calcium antagonist-III : a multiple dose study on healthy volunteers. [in Japanese]. Rinsho Iyaku 2000;16:191-205","journal-title":"Rinsho Iyaku"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200363230-00004"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.26.201"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199902000-00003"},{"key":"e_1_3_3_62_1","first-page":"943","article-title":"Efficacy and safety of CS-905 (azelnidipine) monotherapy on essential hypertension in the long-term treatment [in Japanese]","volume":"15","author":"Yoshinaga K","year":"1999","unstructured":"Yoshinaga K, Iimura O, Abe K, et al. Efficacy and safety of CS-905 (azelnidipine) monotherapy on essential hypertension in the long-term treatment [in Japanese]. Rinsho Iyaku 1999;15:943-83","journal-title":"Rinsho Iyaku"},{"key":"e_1_3_3_63_1","first-page":"505","article-title":"Efficacy and safety of CS-905 (azelnidipine) combination therapy on essential hypertension [in Japanese]","volume":"15","author":"Hirai A","year":"1999","unstructured":"Hirai A, Terano T, Saito Y. Efficacy and safety of CS-905 (azelnidipine) combination therapy on essential hypertension [in Japanese]. Rinsho Iyaku 1999;15:505-1545","journal-title":"Rinsho Iyaku"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1586\/erc.12.74"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1177\/147323000403200210"},{"key":"e_1_3_3_66_1","first-page":"215","article-title":"Azelnidipine, a dihydropyridine-based calcium antagonist, inhibits angiotensin II-induced oxidative stress generation and downregulation of pigment epithelium-derived factor mRNA levels in microvascular endothelial cells","volume":"31","author":"Matsui T","year":"2005","unstructured":"Matsui T, Yamagishi S, Nakamura K, et al. Azelnidipine, a dihydropyridine-based calcium antagonist, inhibits angiotensin II-induced oxidative stress generation and downregulation of pigment epithelium-derived factor mRNA levels in microvascular endothelial cells. Drugs Exp Clin Res 2005;31:215-19","journal-title":"Drugs Exp Clin Res"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2007.02.022"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000113627.08110.6f"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000244956.47114.c1"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1097\/MAJ.0b013e318065c254"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.K07-063"},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.31.1147"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2011.67"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.1586\/erc.12.159"},{"key":"e_1_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2006.07.030"},{"key":"e_1_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000242414.96277.95"},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2006.09.028"},{"key":"e_1_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0102813"},{"key":"e_1_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.33.1148"},{"key":"e_1_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00595-006-3367-6"},{"key":"e_1_3_3_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2013.02.073"},{"key":"e_1_3_3_82_1","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.23406"},{"key":"e_1_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.1177\/1074248413511692"},{"key":"e_1_3_3_84_1","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.28.1017"},{"key":"e_1_3_3_85_1","doi-asserted-by":"publisher","DOI":"10.1080\/10641960601096745"},{"key":"e_1_3_3_86_1","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0b013e318192690e"},{"key":"e_1_3_3_87_1","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.30.359"},{"key":"e_1_3_3_88_1","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2011.184"},{"key":"e_1_3_3_89_1","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000000270"},{"key":"e_1_3_3_90_1","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-8-23"},{"key":"e_1_3_3_91_1","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R600021-JLR200"},{"key":"e_1_3_3_92_1","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2009.163"},{"key":"e_1_3_3_93_1","doi-asserted-by":"publisher","DOI":"10.4330\/wjc.v6.i7.517"}],"container-title":["Expert Review of Cardiovascular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1586\/14779072.2015.986464","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T11:53:26Z","timestamp":1763726006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1586\/14779072.2015.986464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":89,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1,2]]}},"alternative-id":["10.1586\/14779072.2015.986464"],"URL":"https:\/\/doi.org\/10.1586\/14779072.2015.986464","relation":{},"ISSN":["1477-9072","1744-8344"],"issn-type":[{"type":"print","value":"1477-9072"},{"type":"electronic","value":"1744-8344"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierk20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierk20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2014-12-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}